Rigel Pharmaceuticals (RIGL) FCF Margin Growth (5y) (2015 - 2026)
Rigel Pharmaceuticals (RIGL) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Rigel Pharmaceuticals | 696.99 Mn | 550.30 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,926.00 |
| Dec 31, 2025 | 12,206.00 |
| Sep 30, 2025 | 14,145.00 |
| Jun 30, 2025 | 11,360.00 |
| Mar 31, 2025 | 496.00 |
| Dec 31, 2024 | 9,754.00 |
| Sep 30, 2024 | 10,931.00 |
| Jun 30, 2024 | 16,066.00 |
| Mar 31, 2024 | -1,251.00 |
| Dec 31, 2023 | -4,809.00 |
| Sep 30, 2023 | 41,111.00 |
| Jun 30, 2023 | 157,091.00 |
| Dec 31, 2022 | -47,886.00 |
| Sep 30, 2022 | 190,656.00 |
| Mar 31, 2022 | 42,384.00 |
| Dec 31, 2021 | 35,552.00 |
| Sep 30, 2021 | 53,373.00 |
| Jun 30, 2021 | 42,549.00 |
| Mar 31, 2021 | 42,757.00 |
| Dec 31, 2020 | 7,261.00 |